Judy Q.

French Village, MO

Judy Shares Her Experience With Cellular Therapy for Her COPD

Age: 75  |  Location: French Village, MO  |  Condition: COPD

Judy Q’s COPD caused many challenges in her daily life, including not being able to walk from room to room in her home, clean the house or do laundry. A couple of years prior to her treatment, Judy asked her doctor for his opinion regarding cellular therapy only to be told that she wasn’t ready for that yet. Judy waited, thinking the doctor would tell her when she was ready, but he didn’t. After being told she needed to go into Hospice, Judy decided to take a proactive approach and scheduled her treatment at the Lung Institute.

Before treatment, Judy felt depressed and like she couldn’t do anything. However, after treatment, Judy noticed gradual improvement, saying that she “started doing things that just kind of came about” without thinking about it. Her family and friends have noticed a difference, and Judy is able to spend more time with them. As Judy says, “My whole way of life is much better.”

If you or a loved one has COPD and would like to learn more about cellular therapy options, contact us at 888-745-6697.

Nancy H.
Bellingham, WA
David V.
Englewood, FL
Herbert K.
Keller, TX
Don C.
Lakewood, OH
Kathleen B.
Amherst, OH
Denise F.
Smiths Creek, MI
Judy Q.
French Village, MO
Penny K.
Omaha, NE
Ronnie G.
Warren, TX
Bill B.
Wellsboro, PA
Joseph O.
Selden, NY
Rhonda S.
Macomb, MI
Tammi S.
Cleveland, OH
Becky D.
Schererville, IN
Rickie S.
Elizabeth City, NC
Brad E.
Nashville, TN
Paul B.
Chagrin Falls, OH
Lois S.
Sun City, AZ
Karl T.
Hampstead, NC
June B.
Madeira Beach, FL
Jim D.
Boca Raton, FL
Marvin S.
Lakeland, FL
Vickie B.
San Antonio, TX
Audrey S.
Fairbanks, AK
Linus S.
Hays, KS

* Every patient is given a Patient Satisfaction Survey shortly after treatment. Responses to the 11-question survey are aggregated to determine patient satisfaction with the delivery of treatment.

^ Quality of Life Survey data measured the patient’s self-assessed quality of life and measurable quality of improvement at three months of COPD patients.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.

Each patient is different. Results may vary.